Cargando…
Magnetic Resonance Imaging–Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
IMPORTANCE: Transrectal, ultrasonography-guided prostate biopsy often fails to disclose the severity of underlying pathologic findings for prostate cancer. Magnetic resonance imaging (MRI)–guided biopsy may improve the characterization of prostate pathologic results, but few studies have examined it...
Autores principales: | Jayadevan, Rajiv, Felker, Ely R., Kwan, Lorna, Barsa, Danielle E., Zhang, Haoyue, Sisk, Anthony E., Delfin, Merdie, Marks, Leonard S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739900/ https://www.ncbi.nlm.nih.gov/pubmed/31509206 http://dx.doi.org/10.1001/jamanetworkopen.2019.11019 |
Ejemplares similares
-
Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes
por: Aker, Mamdouh N., et al.
Publicado: (2023) -
Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020) -
Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging
por: Topoozian, Mark, et al.
Publicado: (2023) -
Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance
por: Salguero, Joseba, et al.
Publicado: (2021) -
Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy
por: Connor, Martin J., et al.
Publicado: (2020)